These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 11474872

  • 1. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
    Morin A, Guimarey L, Apezteguia M, Santucci Z.
    Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
    [Abstract] [Full Text] [Related]

  • 2. Adult height in Turner Syndrome girls after long-term growth hormone treatment.
    Morin A, Guimarey LM, Apezteguia M, Santucci ZC.
    Medicina (B Aires); 2009; 69(4):431-6. PubMed ID: 19770097
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience.
    Plotnick L, Attie KM, Blethen SL, Sy JP.
    Pediatrics; 1998 Aug; 102(2 Pt 3):479-81. PubMed ID: 9685447
    [Abstract] [Full Text] [Related]

  • 4. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A, Guimarey L, Santucci Z, Apezteguia M.
    Medicina (B Aires); 2000 Aug; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [Abstract] [Full Text] [Related]

  • 5. Final height in estrogen-treated patients with Turner syndrome.
    Demetriou E, Emans SJ, Crigler JF.
    Obstet Gynecol; 1984 Oct; 64(4):459-64. PubMed ID: 6091005
    [Abstract] [Full Text] [Related]

  • 6. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Oct; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 7. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G, Trebar B, Baur F, Schweizer R, Ranke MB.
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [Abstract] [Full Text] [Related]

  • 8. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Apr; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 9. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO, KIGS International Board.
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [Abstract] [Full Text] [Related]

  • 10. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
    Davenport ML.
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
    [Abstract] [Full Text] [Related]

  • 11. Treatment outcome in Turner syndrome.
    Parvin M, Roche E, Costigan C, Hoey HM.
    Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
    [Abstract] [Full Text] [Related]

  • 12. [Turner syndrome: a virtually certain indication for growth hormone treatment].
    Rongen-Westerlaken C, Wit JM.
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):155-63. PubMed ID: 1448805
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 15. Optimizing estrogen replacement treatment in Turner syndrome.
    Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP.
    Pediatrics; 1998 Aug; 102(2 Pt 3):486-8. PubMed ID: 9685449
    [Abstract] [Full Text] [Related]

  • 16. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [Abstract] [Full Text] [Related]

  • 18. Improved final height in Turner's syndrome following growth-promoting treatment at a single centre.
    Gault EJ, Paterson WF, Young D, Donaldson MD.
    Acta Paediatr; 2003 Sep; 92(9):1033-8. PubMed ID: 14599065
    [Abstract] [Full Text] [Related]

  • 19. Turner syndrome, insulin sensitivity and growth hormone treatment.
    Mazzanti L, Bergamaschi R, Castiglioni L, Zappulla F, Pirazzoli P, Cicognani A.
    Horm Res; 2005 Sep; 64 Suppl 3():51-7. PubMed ID: 16439845
    [Abstract] [Full Text] [Related]

  • 20. [Optimizing estrogen treatment in Turner syndrome].
    Ságodi L, Sólyom E.
    Orv Hetil; 2003 Mar 23; 144(12):563-8. PubMed ID: 12723527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.